Le Lézard
Classified in: Science and technology
Subject: Product/Service

New DART-MX93 System on Module by Variscite Brings Machine Learning to Compact, Cost-Optimized, Rugged Edge Devices


Variscite, a leading worldwide System on Module (SoM) designer, developer and manufacturer, today announced the newest member of the DART Pin2Pin family for machine learning on edge devices at a competitive price for markets like industrial, IoT, smart devices, and wearables.

At only 55 x 30 millimeters?about half the size of a credit card?the DART-MX93 enables machine learning, even in compact devices. Its energy-flex architecture provides efficient processing; built-in security ensures data and applications are protected.

Similar to the successful VAR-SOM-MX93 which was already launched by Variscite in 2023, the DART-MX93 is based on the same NXP iMX93 processor with up to 1.7GHz Dual Cortextm-A55, and 250MHz Cortex-M33 real-time co-processor, equipped with the Arm® neural processing unit Ethostm-U65 microNPU. The new SoM includes robust features like 2x CAN bus, 2x GbE, and industrial temperature grade plus a wide range of features and connectivity options: camera inputs, audio in/out, ADC, 2x USB, certified Wi-Fi 6 dual-band 802.11 ax/ac/a/b/g/n with optional 802.15.4, BT/BLE 5.3, and LVDS display outputs.

"Variscite's DART-MX93 is another breakthrough that offers advanced processing power and energy-efficiency with industrial-grade features at an extremely attractive price," said Ofer Austerlitz, VP Business Development and Sales of Variscite. "The DART-MX93 is positioned to enable a new class of smart edge devices that are rugged, energy-wise, performant, and affordable in volume."

Variscite offers the broadest range of SoMs based on NXP's i.MX 9 series. The upcoming VAR-SOM-MX91, to be released in parallel with NXP's iMX91, is ideal for price-sensitive devices. The DART-MX95, powered by NXP i.MX95, was created for powerful edge platforms that demand high performance, high-end graphics, AI/ML capabilities, advanced security and safety functions, and a rich set of high-speed connectivity options.

Longevity and Upgrade Path

Variscite's DART-MX93 is included in the company's long-term longevity plan and is expected to be available to customers for the next 15 years.

The DART-MX93 is part of the DART Pin2Pin family that gives Variscite customers a future-proof way to scale their device capabilities with new generations of DART SoMs. This ensures extended longevity for customer products, as well as reduces development time, costs, and risks for future product iterations. From the i.MX8M Mini, through the i.MX8M and iMX8M Plus, to the i.MX 95.

Availability

Variscite's alpha customers can now place orders in production quantities for DART-MX93 SoMs starting at $39 per unit. DART-MX93 evaluation kits, which include the scalable VAR-DT8M custom board and an optional LVDS display with a touch panel, are also available.

ABOUT VARISCITE

Variscite is a worldwide leading System on Module designer and manufacturer, setting the bar for embedded solutions since 2003 with high-quality modules. The company provides the broadest ARM-based SoM portfolio in the embedded market with a wide range of configuration options that cover an entire embedded product and application range; from entry-level to high-performance solutions. Variscite's in-house production fully complies with the strict medical ISO13485 and ISO9001 standards. Along with the company's ongoing online documentation and personal support as well as the generous longevity, the company's customers are enjoying consistent, reliable products and services starting from the earliest development stages throughout the end-product lifecycle.


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: